top of page
Search

Novel Pacemakers Alternative

By Aarav Shah;

Technology Columnist; The Lawrenceville School, NJ


Conventionally, pacemakers are frequently used by many patients worldwide in an effort to establish a regular, consistent, and rhythmic heartbeat. In more detail, pacemakers are small, battery-operated devices that have an objective of ensuring that the heartbeat is not at too slow of a pace. There are multiple different types and variations of pacemakers: single chamber pacemakers, dual chamber pacemakers, and biventricular pacemakers. The distinction between the single and dual chamber pacemakers are the locations of the heart in which electrical signals are transmitted - the lower right chamber and both the lower right chamber and upper right chamber, respectively. The biventricular pacemaker is designed for patients who experienced either a heart failure or slow heartbeats. However, the one downside to the otherwise effective pacemakers is the surgical procedure required to utilize the devices. Invasive the first time, pacemakers also often require surgery approximately every five years to ensure the battery life is rejuvenated.


However, a group of California and MIT scientists and researchers have collectively published an alternative to the conventional pacemaker, one that sticks to a patient's chest and emits ultrasound waves to signal the heart to beat. Yet, the ultrasound waves are not the only innovative feature of this revised pacemaker. A gene therapy procedure, non-invasive in nature, is administered to enable the heart cells to effectively respond to the ultrasound waves. Since June 10, 2026, this novel approach has been successfully tested in rats and pig hearts, as well as select samples of human heart cells. The specific biological process of this alternative pacemaker is largely focused and tailored towards helping the heart cells register and effectively respond to the introduced ultrasound waves. The gene therapy injection encourages the cells to make a sound-sensitive protein that are located on the heart cells' membranes. Countless ethical concerns regarding this approach include concerns regarding whether or not the DNA of an individual is altered throughout the gene therapy injection.


Fortunately, the RNA is the only thing impacted, not the DNA, whereby the RNA is instructed to produce the sound-sensitive proteins and not manipulate the existing genetic information. Ultimately, through this gene therapy process, the ion channels of the heart cells are prompted to bring in calcium. In turn, the entrance of calcium is a factor that results in the heart to beat at a normal, steady, and not-too-slow pace. Despite the biologically viable nature of this ultrasound replacement for traditional and conventional pacemakers, there are concerns stemming from the Food and Drug Administration's (FDA) approval of this device and the challenge of having this device enter the mainstream conversation of traditional pacemakers. First, when it comes to gene therapy procedures in general, the FDA is careful to consider the safety, monetary, and regulation of the concept at hand. Second, with many patients used to the traditional route, there is always the burden of convincing long-lasting pacemaker supporters to switch to using this ultrasound alternative. 



Although there are many upsides to this product, it is important to recognize the feasibility of the ultrasound pacemaker's usage and strive to improve the audience outreach of the novel biomedical innovation.


Works Cited 


Chu, Jennifer. (2026, June 2). Ultrasound-Based Pacemaker Noninvasively Steadies the Heart. Retrieved from 


Mayo Clinic. (n.d). Pacemaker. Retrieved from 


Music, Alex. (2026, June 10). Ultrasound Patch Could Form Future Pacemaker. Retrieved from https://spectrum.ieee.org/pacemaker-and-ultrasound

Comments

bottom of page